Zidovudine plus didanosine in primary HIV-1 infection

Antiviral Therapy

Volumn 2, Issue 1, 1997, Pages 5-11

  Perrin, Luc ^a  

^a Laboratory of Virology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; PLACEBO; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; VIREMIA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; CD4-CD8 RATIO; DIDANOSINE; DRUG THERAPY, COMBINATION; FEMALE; HIV-1; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; ZIDOVUDINE;

EID: 0030917766     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Tindall B, Barker S. Donovan B. Barnes T, Roberts J, Kronenberg C, Gold J, Penny R. Cooper D & The Sydney AIDS Study Group. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Archives of Internal Medicine 1988; 148:945-949.
2. Pedersen C, Nielsen JO, Dickmeis E & Jordal R. Early progression to AIDS following primary HIV infection. AIDS 1989; 3:45-47.
3. 6. AIDS, and death from AIDS? British Medical Journal 1995; 309:1535-1537.
4. Piatak M, Saag MS, Yang LC, Clarck SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM & Lifson JD. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993; 259:1749-1754.
5. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M. Fox CH, Orenstein JM, Kotler DP & Fauci SA. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362:355-358.